“MDMA-Assisted Psychotherapy for PTSD Research: Bridging Biology and Psychology”
SYNOPSIS: In this discussion we will take a quick look at the overall structure of a clinical research program and the steps/time and strategy needed to take MDMA from experimental to prescription. I will also provide an overview of the exciting progress of MAPS MDMA/PTSD studies to date with a review of study results so far. After taking a look at the big picture of the clinical studies we will dive into what happens in the actual treatment. We will look at why might be happening on a biological level and how this relates to the therapeutic process. What are the elements of the therapy and how do we try to standardize the process while leaving room for the individual therapist and participant.
AMY EMERSON
Director of Clinical Research, Multidisciplinary Association for Psychedelic Studies
BIOGRAPHY: Amy earned her BS in genetics and cell biology from Washington State University. She has worked in clinical development and research for the last 15 years in the fields of immunology (Applied Immune Sciences), oncology (RPR), and most recently in vaccine development (Chiron and Novartis). Amy has worked with MAPS as a volunteer since 2003 facilitating the development of the MDMA clinical program. She is currently working as Director of Clinical Research and is involved with creating the structure needed to support the growing needs of the clinical operations group and MAPS clinical research studies.
Horizons: Perspectives on Psychedelics is an annual forum that examines the role of psychedelic drugs in science, medicine, culture and spirituality.
More information at HorizonsNYC.org
- Horizons 2012: AMY EMERSON “MDMA-Assisted Psychotherapy for PTSD Research ( Download)
- Regulations for Drug Research - Amy Emerson & Michelle Weitz - Part 1 of 2 ( Download)
- Horizons 2015: RICK DOBLIN, Ph.D. “FDA Approval of MDMA-assisted Psychotherapy: On the Horizon” ( Download)
- Horizons 2017: SHANNON CLARE CARLIN, MA, IMF Vision Becomes Reality: Making a Legal MDMA Therapist ( Download)
- Michael Mithoefer - MDMA-Assisted Psychotherapy: Determining candidates ( Download)
- Michael Mithoefer - MDMA-Assisted Psychotherapy: The Risks and Benefits ( Download)
- Principles of MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder Workshop - Part 2/4 ( Download)
- RHR: Treating PTSD with MDMA, Dr Michael Mithoefer ( Download)
- Nordic Reform Conference 2019: Child Abuse, Trauma, Addictions and MDMA-assisted Psychotherapy ( Download)
- PTSD & MDMA Psychotherapy: A First-Hand Account ~ Lori Tipton ( Download)
- MAPS Overview and MDMA FDA Approval Status - EntheoGeneration 2019 ( Download)
- Rick Doblin MAPS CIIS Psychedelic assisted Psychotherapy ( Download)
- Psychedelic Mystical Experiences, Social Change & Therapeutic Outcomes - Rick Doblin ( Download)
- From Adam to Ecstasy to Prescription MDMA Over Four Decades ( Download)
- Psychedelic Stocks | Hype or The Future ( Download)
